0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Clinical Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-2E14234
Home | Market Reports | Health| Medical Devices & Equipment
Global Clinical Hemostatic Material Market Research Report 2023
BUY CHAPTERS

Clinical Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2E14234
Report
September 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Hemostatic Material - Market Size

The global market for Clinical Hemostatic Material was estimated to be worth US$ 525 million in 2023 and is forecast to a readjusted size of US$ 898.2 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Clinical Hemostatic Material - Market

Clinical Hemostatic Material - Market

Hemostatic materials can be used to stop bleeding, and the process is realized following various ways. For example, gauze, a traditional hemostatic material, can be used to stop bleeding under conditions of physical compression (realized using pressure wraps). Hemostatic sponges function as efficient absorbents.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clinical Hemostatic Material, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clinical Hemostatic Material by region & country, by Type, and by Application.
The Clinical Hemostatic Material market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Hemostatic Material.
Market Segmentation

Scope of Clinical Hemostatic Material - Market Report

Report Metric Details
Report Name Clinical Hemostatic Material - Market
Forecasted market size in 2030 US$ 898.2 million
CAGR 8.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Natural Biological Material
  • Synthetic
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Clinical Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Clinical Hemostatic Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Clinical Hemostatic Material in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Clinical Hemostatic Material - Market size in 2030?

Ans: The Clinical Hemostatic Material - Market size in 2030 will be US$ 898.2 million.

Who are the main players in the Clinical Hemostatic Material - Market report?

Ans: The main players in the Clinical Hemostatic Material - Market are Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products

What are the Application segmentation covered in the Clinical Hemostatic Material - Market report?

Ans: The Applications covered in the Clinical Hemostatic Material - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Clinical Hemostatic Material - Market report?

Ans: The Types covered in the Clinical Hemostatic Material - Market report are Natural Biological Material, Synthetic

1 Market Overview
1.1 Clinical Hemostatic Material Product Introduction
1.2 Global Clinical Hemostatic Material Market Size Forecast
1.2.1 Global Clinical Hemostatic Material Sales Value (2019-2030)
1.2.2 Global Clinical Hemostatic Material Sales Volume (2019-2030)
1.2.3 Global Clinical Hemostatic Material Sales Price (2019-2030)
1.3 Clinical Hemostatic Material Market Trends & Drivers
1.3.1 Clinical Hemostatic Material Industry Trends
1.3.2 Clinical Hemostatic Material Market Drivers & Opportunity
1.3.3 Clinical Hemostatic Material Market Challenges
1.3.4 Clinical Hemostatic Material Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clinical Hemostatic Material Players Revenue Ranking (2023)
2.2 Global Clinical Hemostatic Material Revenue by Company (2019-2024)
2.3 Global Clinical Hemostatic Material Players Sales Volume Ranking (2023)
2.4 Global Clinical Hemostatic Material Sales Volume by Company Players (2019-2024)
2.5 Global Clinical Hemostatic Material Average Price by Company (2019-2024)
2.6 Key Manufacturers Clinical Hemostatic Material Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Clinical Hemostatic Material Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Clinical Hemostatic Material
2.9 Clinical Hemostatic Material Market Competitive Analysis
2.9.1 Clinical Hemostatic Material Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Clinical Hemostatic Material Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Hemostatic Material as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural Biological Material
3.1.2 Synthetic
3.2 Global Clinical Hemostatic Material Sales Value by Type
3.2.1 Global Clinical Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clinical Hemostatic Material Sales Value, by Type (2019-2030)
3.2.3 Global Clinical Hemostatic Material Sales Value, by Type (%) (2019-2030)
3.3 Global Clinical Hemostatic Material Sales Volume by Type
3.3.1 Global Clinical Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Clinical Hemostatic Material Sales Volume, by Type (2019-2030)
3.3.3 Global Clinical Hemostatic Material Sales Volume, by Type (%) (2019-2030)
3.4 Global Clinical Hemostatic Material Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Clinical Hemostatic Material Sales Value by Application
4.2.1 Global Clinical Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clinical Hemostatic Material Sales Value, by Application (2019-2030)
4.2.3 Global Clinical Hemostatic Material Sales Value, by Application (%) (2019-2030)
4.3 Global Clinical Hemostatic Material Sales Volume by Application
4.3.1 Global Clinical Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Clinical Hemostatic Material Sales Volume, by Application (2019-2030)
4.3.3 Global Clinical Hemostatic Material Sales Volume, by Application (%) (2019-2030)
4.4 Global Clinical Hemostatic Material Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Clinical Hemostatic Material Sales Value by Region
5.1.1 Global Clinical Hemostatic Material Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clinical Hemostatic Material Sales Value by Region (2019-2024)
5.1.3 Global Clinical Hemostatic Material Sales Value by Region (2025-2030)
5.1.4 Global Clinical Hemostatic Material Sales Value by Region (%), (2019-2030)
5.2 Global Clinical Hemostatic Material Sales Volume by Region
5.2.1 Global Clinical Hemostatic Material Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Clinical Hemostatic Material Sales Volume by Region (2019-2024)
5.2.3 Global Clinical Hemostatic Material Sales Volume by Region (2025-2030)
5.2.4 Global Clinical Hemostatic Material Sales Volume by Region (%), (2019-2030)
5.3 Global Clinical Hemostatic Material Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Clinical Hemostatic Material Sales Value, 2019-2030
5.4.2 North America Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Clinical Hemostatic Material Sales Value, 2019-2030
5.5.2 Europe Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Clinical Hemostatic Material Sales Value, 2019-2030
5.6.2 Asia Pacific Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Clinical Hemostatic Material Sales Value, 2019-2030
5.7.2 South America Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Clinical Hemostatic Material Sales Value, 2019-2030
5.8.2 Middle East & Africa Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clinical Hemostatic Material Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clinical Hemostatic Material Sales Value
6.2.1 Key Countries/Regions Clinical Hemostatic Material Sales Value, 2019-2030
6.2.2 Key Countries/Regions Clinical Hemostatic Material Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Clinical Hemostatic Material Sales Value, 2019-2030
6.3.2 United States Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clinical Hemostatic Material Sales Value, 2019-2030
6.4.2 Europe Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clinical Hemostatic Material Sales Value, 2019-2030
6.5.2 China Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clinical Hemostatic Material Sales Value, 2019-2030
6.6.2 Japan Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clinical Hemostatic Material Sales Value, 2019-2030
6.7.2 South Korea Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clinical Hemostatic Material Sales Value, 2019-2030
6.8.2 Southeast Asia Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clinical Hemostatic Material Sales Value, 2019-2030
6.9.2 India Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clinical Hemostatic Material Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Clinical Hemostatic Material Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Introduction and Business Overview
7.2.3 BD Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BD Clinical Hemostatic Material Product Offerings
7.2.5 BD Recent Development
7.3 Baxter
7.3.1 Baxter Company Information
7.3.2 Baxter Introduction and Business Overview
7.3.3 Baxter Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Baxter Clinical Hemostatic Material Product Offerings
7.3.5 Baxter Recent Development
7.4 B.Braun
7.4.1 B.Braun Company Information
7.4.2 B.Braun Introduction and Business Overview
7.4.3 B.Braun Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.4.4 B.Braun Clinical Hemostatic Material Product Offerings
7.4.5 B.Braun Recent Development
7.5 Cura Medical
7.5.1 Cura Medical Company Information
7.5.2 Cura Medical Introduction and Business Overview
7.5.3 Cura Medical Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cura Medical Clinical Hemostatic Material Product Offerings
7.5.5 Cura Medical Recent Development
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Company Information
7.6.2 GELITA MEDICAL Introduction and Business Overview
7.6.3 GELITA MEDICAL Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GELITA MEDICAL Clinical Hemostatic Material Product Offerings
7.6.5 GELITA MEDICAL Recent Development
7.7 Curasan AG
7.7.1 Curasan AG Company Information
7.7.2 Curasan AG Introduction and Business Overview
7.7.3 Curasan AG Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Curasan AG Clinical Hemostatic Material Product Offerings
7.7.5 Curasan AG Recent Development
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Company Information
7.8.2 Meril Life Sciences Introduction and Business Overview
7.8.3 Meril Life Sciences Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Meril Life Sciences Clinical Hemostatic Material Product Offerings
7.8.5 Meril Life Sciences Recent Development
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Company Information
7.9.2 Zhonghui Shengxi Introduction and Business Overview
7.9.3 Zhonghui Shengxi Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zhonghui Shengxi Clinical Hemostatic Material Product Offerings
7.9.5 Zhonghui Shengxi Recent Development
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Company Information
7.10.2 Beijing Datsing Bio-tech Introduction and Business Overview
7.10.3 Beijing Datsing Bio-tech Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Beijing Datsing Bio-tech Clinical Hemostatic Material Product Offerings
7.10.5 Beijing Datsing Bio-tech Recent Development
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Company Information
7.11.2 Guizhou Jin Jiu Biotech Introduction and Business Overview
7.11.3 Guizhou Jin Jiu Biotech Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Guizhou Jin Jiu Biotech Clinical Hemostatic Material Product Offerings
7.11.5 Guizhou Jin Jiu Biotech Recent Development
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Company Information
7.12.2 Beijing Taikesiman Introduction and Business Overview
7.12.3 Beijing Taikesiman Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Beijing Taikesiman Clinical Hemostatic Material Product Offerings
7.12.5 Beijing Taikesiman Recent Development
7.13 Foryou Medical
7.13.1 Foryou Medical Company Information
7.13.2 Foryou Medical Introduction and Business Overview
7.13.3 Foryou Medical Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Foryou Medical Clinical Hemostatic Material Product Offerings
7.13.5 Foryou Medical Recent Development
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Company Information
7.14.2 Saikesaisi Holdings Group Introduction and Business Overview
7.14.3 Saikesaisi Holdings Group Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Saikesaisi Holdings Group Clinical Hemostatic Material Product Offerings
7.14.5 Saikesaisi Holdings Group Recent Development
7.15 Biotemed
7.15.1 Biotemed Company Information
7.15.2 Biotemed Introduction and Business Overview
7.15.3 Biotemed Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Biotemed Clinical Hemostatic Material Product Offerings
7.15.5 Biotemed Recent Development
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Company Information
7.16.2 Hangzhou Singclean Medical Products Introduction and Business Overview
7.16.3 Hangzhou Singclean Medical Products Clinical Hemostatic Material Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Hangzhou Singclean Medical Products Clinical Hemostatic Material Product Offerings
7.16.5 Hangzhou Singclean Medical Products Recent Development
8 Industry Chain Analysis
8.1 Clinical Hemostatic Material Industrial Chain
8.2 Clinical Hemostatic Material Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clinical Hemostatic Material Sales Model
8.5.2 Sales Channel
8.5.3 Clinical Hemostatic Material Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Clinical Hemostatic Material Market Trends
    Table 2. Clinical Hemostatic Material Market Drivers & Opportunity
    Table 3. Clinical Hemostatic Material Market Challenges
    Table 4. Clinical Hemostatic Material Market Restraints
    Table 5. Global Clinical Hemostatic Material Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Clinical Hemostatic Material Revenue Market Share by Company (2019-2024)
    Table 7. Global Clinical Hemostatic Material Sales Volume by Company (2019-2024) & (Tons)
    Table 8. Global Clinical Hemostatic Material Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Clinical Hemostatic Material Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Clinical Hemostatic Material Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Clinical Hemostatic Material Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Clinical Hemostatic Material
    Table 13. Global Clinical Hemostatic Material Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Hemostatic Material as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Clinical Hemostatic Material Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Clinical Hemostatic Material Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Clinical Hemostatic Material Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Clinical Hemostatic Material Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Clinical Hemostatic Material Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Clinical Hemostatic Material Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
    Table 22. Global Clinical Hemostatic Material Sales Volume by Type (2019-2024) & (Tons)
    Table 23. Global Clinical Hemostatic Material Sales Volume by Type (2025-2030) & (Tons)
    Table 24. Global Clinical Hemostatic Material Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Clinical Hemostatic Material Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Clinical Hemostatic Material Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Clinical Hemostatic Material Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Clinical Hemostatic Material Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Clinical Hemostatic Material Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Clinical Hemostatic Material Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Clinical Hemostatic Material Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Clinical Hemostatic Material Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Clinical Hemostatic Material Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
    Table 34. Global Clinical Hemostatic Material Sales Volume by Application (2019-2024) & (Tons)
    Table 35. Global Clinical Hemostatic Material Sales Volume by Application (2025-2030) & (Tons)
    Table 36. Global Clinical Hemostatic Material Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Clinical Hemostatic Material Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Clinical Hemostatic Material Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Clinical Hemostatic Material Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Clinical Hemostatic Material Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Clinical Hemostatic Material Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Clinical Hemostatic Material Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Clinical Hemostatic Material Sales Value by Region (2019-2024) & (%)
    Table 44. Global Clinical Hemostatic Material Sales Value by Region (2025-2030) & (%)
    Table 45. Global Clinical Hemostatic Material Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
    Table 46. Global Clinical Hemostatic Material Sales Volume by Region (2019-2024) & (Tons)
    Table 47. Global Clinical Hemostatic Material Sales Volume by Region (2025-2030) & (Tons)
    Table 48. Global Clinical Hemostatic Material Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Clinical Hemostatic Material Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Clinical Hemostatic Material Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Clinical Hemostatic Material Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Clinical Hemostatic Material Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Clinical Hemostatic Material Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Clinical Hemostatic Material Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Clinical Hemostatic Material Sales Volume, (2019-2024) & (Tons)
    Table 56. Key Countries/Regions Clinical Hemostatic Material Sales Volume, (2025-2030) & (Tons)
    Table 57. Johnson & Johnson Company Information
    Table 58. Johnson & Johnson Introduction and Business Overview
    Table 59. Johnson & Johnson Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. Johnson & Johnson Clinical Hemostatic Material Product Offerings
    Table 61. Johnson & Johnson Recent Development
    Table 62. BD Company Information
    Table 63. BD Introduction and Business Overview
    Table 64. BD Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. BD Clinical Hemostatic Material Product Offerings
    Table 66. BD Recent Development
    Table 67. Baxter Company Information
    Table 68. Baxter Introduction and Business Overview
    Table 69. Baxter Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Baxter Clinical Hemostatic Material Product Offerings
    Table 71. Baxter Recent Development
    Table 72. B.Braun Company Information
    Table 73. B.Braun Introduction and Business Overview
    Table 74. B.Braun Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. B.Braun Clinical Hemostatic Material Product Offerings
    Table 76. B.Braun Recent Development
    Table 77. Cura Medical Company Information
    Table 78. Cura Medical Introduction and Business Overview
    Table 79. Cura Medical Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. Cura Medical Clinical Hemostatic Material Product Offerings
    Table 81. Cura Medical Recent Development
    Table 82. GELITA MEDICAL Company Information
    Table 83. GELITA MEDICAL Introduction and Business Overview
    Table 84. GELITA MEDICAL Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. GELITA MEDICAL Clinical Hemostatic Material Product Offerings
    Table 86. GELITA MEDICAL Recent Development
    Table 87. Curasan AG Company Information
    Table 88. Curasan AG Introduction and Business Overview
    Table 89. Curasan AG Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 90. Curasan AG Clinical Hemostatic Material Product Offerings
    Table 91. Curasan AG Recent Development
    Table 92. Meril Life Sciences Company Information
    Table 93. Meril Life Sciences Introduction and Business Overview
    Table 94. Meril Life Sciences Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 95. Meril Life Sciences Clinical Hemostatic Material Product Offerings
    Table 96. Meril Life Sciences Recent Development
    Table 97. Zhonghui Shengxi Company Information
    Table 98. Zhonghui Shengxi Introduction and Business Overview
    Table 99. Zhonghui Shengxi Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 100. Zhonghui Shengxi Clinical Hemostatic Material Product Offerings
    Table 101. Zhonghui Shengxi Recent Development
    Table 102. Beijing Datsing Bio-tech Company Information
    Table 103. Beijing Datsing Bio-tech Introduction and Business Overview
    Table 104. Beijing Datsing Bio-tech Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 105. Beijing Datsing Bio-tech Clinical Hemostatic Material Product Offerings
    Table 106. Beijing Datsing Bio-tech Recent Development
    Table 107. Guizhou Jin Jiu Biotech Company Information
    Table 108. Guizhou Jin Jiu Biotech Introduction and Business Overview
    Table 109. Guizhou Jin Jiu Biotech Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 110. Guizhou Jin Jiu Biotech Clinical Hemostatic Material Product Offerings
    Table 111. Guizhou Jin Jiu Biotech Recent Development
    Table 112. Beijing Taikesiman Company Information
    Table 113. Beijing Taikesiman Introduction and Business Overview
    Table 114. Beijing Taikesiman Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 115. Beijing Taikesiman Clinical Hemostatic Material Product Offerings
    Table 116. Beijing Taikesiman Recent Development
    Table 117. Foryou Medical Company Information
    Table 118. Foryou Medical Introduction and Business Overview
    Table 119. Foryou Medical Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 120. Foryou Medical Clinical Hemostatic Material Product Offerings
    Table 121. Foryou Medical Recent Development
    Table 122. Saikesaisi Holdings Group Company Information
    Table 123. Saikesaisi Holdings Group Introduction and Business Overview
    Table 124. Saikesaisi Holdings Group Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 125. Saikesaisi Holdings Group Clinical Hemostatic Material Product Offerings
    Table 126. Saikesaisi Holdings Group Recent Development
    Table 127. Biotemed Company Information
    Table 128. Biotemed Introduction and Business Overview
    Table 129. Biotemed Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 130. Biotemed Clinical Hemostatic Material Product Offerings
    Table 131. Biotemed Recent Development
    Table 132. Hangzhou Singclean Medical Products Company Information
    Table 133. Hangzhou Singclean Medical Products Introduction and Business Overview
    Table 134. Hangzhou Singclean Medical Products Clinical Hemostatic Material Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 135. Hangzhou Singclean Medical Products Clinical Hemostatic Material Product Offerings
    Table 136. Hangzhou Singclean Medical Products Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Clinical Hemostatic Material Downstream Customers
    Table 140. Clinical Hemostatic Material Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Clinical Hemostatic Material Product Picture
    Figure 2. Global Clinical Hemostatic Material Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Clinical Hemostatic Material Sales Volume (2019-2030) & (Tons)
    Figure 5. Global Clinical Hemostatic Material Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Clinical Hemostatic Material Report Years Considered
    Figure 7. Global Clinical Hemostatic Material Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Clinical Hemostatic Material Players Sales Volume Ranking (2023) & (Tons)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Clinical Hemostatic Material Revenue in 2023
    Figure 10. Clinical Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Natural Biological Material Picture
    Figure 12. Synthetic Picture
    Figure 13. Global Clinical Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Clinical Hemostatic Material Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Clinical Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
    Figure 16. Global Clinical Hemostatic Material Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Clinical Hemostatic Material Price by Type (2019-2030) & (US$/Ton)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Clinic
    Figure 20. Product Picture of Other
    Figure 21. Global Clinical Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Clinical Hemostatic Material Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Clinical Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
    Figure 24. Global Clinical Hemostatic Material Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Clinical Hemostatic Material Price by Application (2019-2030) & (US$/Ton)
    Figure 26. North America Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Clinical Hemostatic Material Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Clinical Hemostatic Material Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Clinical Hemostatic Material Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Clinical Hemostatic Material Sales Volume (%), (2019-2030)
    Figure 38. United States Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Clinical Hemostatic Material Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Clinical Hemostatic Material Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Clinical Hemostatic Material Sales Value by Application (%), 2023 VS 2030
    Figure 59. Clinical Hemostatic Material Industrial Chain
    Figure 60. Clinical Hemostatic Material Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Electrosurgical Cutting Electrode Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-18M7037
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Treatment Trolleys Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-7B8751
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Monopolar Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-2L7328
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Cutting Electrosurgical Unit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-35P6799
Sat Oct 12 00:00:00 UTC 2024

Add to Cart